2016 Annual Meeting Speaker Biographies
Murray Grossman, M.D., Ed.D.
Professor of Neurology, Department of Neurology, University of Pennsylvania
Topic: Neural basis for language disorders in primary progressive aphasia
Bio: Dr. Grossman is the Director of the Penn Frontotemporal Degeneration Center and the Chief of the Cognitive Neurology Division, University of Pennsylvania. He has over 350 peer-reviewed publications studying language and cognitive disorders, and associated imaging, biomarker and pathological associations.
Disclosures:
Financial: Dr. Grossman is receives research support from the National Institutes of Health, and receives consulting fees for his role as an associate editor for Neurology. He has received a waiver of his ANCDS conference fee and an honorarium from ANCDS for his presentation today.
Non-financial: No relevant non-financial relationships exist.
Learner outcomes:
- Participants will be able to identify multiple phenotypes of primary progressive aphasia.
- Participants will be able to discuss the language deficits associated with non-aphasic variants of frontotemporal degeneration.
- Participants will be able to discuss the underlying pathologies associated with the various phenotypes of primary progressive aphasia.
David Irwin, M.D.
Assistant Professor of Neurology, Department of Neurology, University of Pennsylvania
Topic: Influence of genetic variants on underlying neuropathology in neurodegenerative disorders
Bio: Dr. Irwin is an Assistant Professor of Neurology at the University of Pennsylvania. His research focuses on the progression and spread of proteinopathies related to ALS, frontotemporal degeneration, and Pick’s disease, and developing ways to diagnose neurodegenerative diseases in vivo.
Disclosures:
Financial: Dr. Irwin has received a waiver of his ANCDS conference fee and an honorarium from ANCDS for his presentation today. No other relevant financial relationships exist.
Non-financial: No relevant non-financial relationships exist.
Learner Outcomes:
- Participants will be able to discuss the clinical, genetic, and pathological heterogeneity of neurodegenerative disorders.
- Participants will be able to discuss the genetic associations in FTLD.
- Participants will be able to discuss the associations of GWAS-associated common risk variants in neurodegenerative disease.
Maya Henry, PhD, CCC-SLP
Assistant Professor, Department of Communication Sciences and Disorders, University of Texas, Austin
Topic: A staged treatment approach for Primary Progressive Aphasia
Bio: Dr. Henry is an Assistant Professor in the Department of Communication Sciences and Disorders at the University of Texas – Austin.
Disclosures:
Financial: Dr. Henry receives salary from the University of Texas – Austin, and receives grant funding from the National Institutes of Health and the Darrell K. Royal Fund for Alzheimer’s Disease. She has received a waiver of her ANCDS conference fee and an honorarium from ANCDS for her presentation today.
Non-financial: No relevant non-financial relationships exist.
Learner outcomes:
- Participants will be able to describe the typical progression of deficits in the variants of primary progressive aphasia (PPA).
- Participants will be able to outline a framework for staged assessment and treatment in PPA.
- Participants will be able to describe approaches to rehabilitation that are appropriate across the severity continuum in PPA.
Jamie Reilly, PhD, CCC-SLP
Associate Professor and Interim Department Chair, Communication Sciences and Disorders, Temple University
Topic: Training and maintaining a lexicon in the face of neurodegeneration: Principles of item selection for formal semantic therapy
Bio: Dr. Reilly is an Associate Professor and Interim Department Chair of Communication Sciences and Disorders at Temple University. He studied linguistics and speech-language pathology prior to completing doctoral and postdoctoral training in cognitive neuroscience at Temple University and the University of Pennsylvania. Dr. Reilly’s research addresses the organization of human semantic memory and its disruption, repair, and maintenance in neurodegenerative conditions such as Alzheimer’s Disease and Frontotemporal Degeneration.
Disclosures:
Financial: Dr. Reilly has received a waiver of his ANCDS conference fee and an honorarium from ANCDS for his presentation today. No other relevant financial relationships exist.
Non-financial: No relevant non-financial relationships exist.
Learner outcomes:
- Participants will be able to describe the effects of semantic impairment on language usage in Alzheimer’s Disease and Frontotemporal Degeneration.
- Participants will be able to discuss principles of item selection for guiding a maintenance therapy targeting retention of a core vocabulary for people with progressive language impairments.
- Participants will be able to distinguish between maintenance, compensatory, and restorative treatment approaches for progressive language impairment.
Jennifer Horner, PhD, JD, BC-ANCDS
Professor and Associate Dean, College of Health Sciences and Professions, Ohio University
Topic: Ethics and legal concepts in neurodegenerative communication disorders
Bio: In January, 2008, Dr. Horner assumed the responsibilities of Associate Dean for Research and Graduate Studies, College of Health Sciences and Professions (formerly College of Health and Human Services) at Ohio University, Athens, Ohio. Her rank is professor (with tenure) in the School of Rehabilitation and Communication Sciences, division of Communication Sciences and Disorders.
Disclosures:
Financial: Dr. Horner receives royalties from Pro-Ed Publisher for sales of the Reading Comprehension Battery for Aphasia. She has received a waiver of her ANCDS conference fee and an honorarium from ANCDS for her presentation today.
Non-financial: No relevant non-financial relationships exist.
Learner outcomes:
- Participants will be able to list biomedical ethics principles and their correspondence to ANCDS and ASHA codes of ethics.
- Participants will be able to describe how the law influences clinical care and research involving individuals with neurodegenerative disorders.
- Participants will be able to summarize contemporary issues involving ethics and legal concepts impacting the care of individuals with neurodegenerative disorders by communication sciences and disorders specialists.
|
